Skip to main content
. Author manuscript; available in PMC: 2009 Dec 1.
Published in final edited form as: J Hypertens. 2008 Dec;26(12):2414–2425. doi: 10.1097/HJH.0b013e328312c86a

Fig. 7.

Fig. 7

Mean blood pressure (a) and plasma concentrations of MBG (b) and endogenous ouabain (c) in subjects with uncomplicated pregnancy (N Pr) and with preeclampsia. Means ± SEM. @ - P < 0.01 vs. N Pr by two-tailed t-test. (d) Activity of NKA in erythrocytes from normotensive pregnant subjects (N Pr) and from patients with preeclampsia treated ex vivo by antiouabain antibody (aOU), Digibind (DGB), and 3E9 anti-MBG mAb. Means ± SEM. By one-way ANOVA followed by Newman–Keuls test: *P < 0.05, **P < 0.01 vs. N Pr; #P < 0.05, ##P < 0.01 vs. untreated preeclampsia erythrocytes. BP, blood pressure; mAb, monoclonal anti-marinobufagenin antibody; MBG, marinobufagenin; NKA, Na/K-ATPase; PE, preeclampsia; EO, endogenous ouabain.